India, Aug. 25 -- The story explores how Ebola exposes deep inequities in global vaccine politics.

While COVID-19 spurred rapid, lavishly funded innovation for rich nations, African outbreaks like Ebola face neglect, slow research and profit-driven delays.

It traces the Zaire-strain vaccine's bioweapon origins, Gavi's intervention, and Africa's renewed vulnerability to the Bundibugyo strain despite new CEPI-backed trials.

Viruses are lethal and nearly impossible to conquer. If one strain of a particular virus is controlled by a vaccine, a new strain emerges, posing a bigger threat. We know this from the harrowing experience of the COVID-19 pandemic, when SARS-COV-2 ran amok and killed millions worldwide. Rich nations scrambled to find ...